9 results
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
corticosteroid; LABA ... long-acting β2-agonist; LAMA ... #Pulmonary #LABA ... #LAMA #SABA #SAMA ... #ICS #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... LAMA: long-acting ... muscarinic antagonist; LABA ... COPD #GOLD2017 #LAMA
Asthma Maintenance Therapy - Stepwise Approach 

Low dose ICS 
-> Low dose ICS/LABA or Med/High dose
> Low dose ICS/LABA ... remember that all ... Respimat is the only LAMA ... Therapy #Management #Pharmacology ... #Pulmonary
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... receptor antagonists; LABA ... Management #Stepwise #Pulmonary ... #StepUp #Treatment ... #Algorithm #Guidelines
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
COPD, asthma, and ACO ... corticosteroids; LABA ... long-acting β2-agonist; LAMA ... #Differences #Algorithm ... #Treatment
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... Beta2 Agonists (LABA ... Here are the LABA ... These combo LABA ... algorithm).
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
specific questions to ask ... murmur 3/6) - Pulmonary ... algorithm to determine ... days before Pulmonary ... Determine if any labs
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... is vital while lab ... & Dry) is the treatment ... #differential #algorithm ... icu #clinical #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... , INC risk PE, Pulmonary ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... lubricants • Pharmacologic